IRIS
GRIGIONI, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 13.166
NA - Nord America 5.935
EU - Europa 3.040
SA - Sud America 962
Continente sconosciuto - Info sul continente non disponibili 199
AF - Africa 131
OC - Oceania 75
Totale 23.508
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 8.883
US - Stati Uniti d'America 5.702
CN - Cina 1.816
IT - Italia 1.463
HK - Hong Kong 1.087
BR - Brasile 705
VN - Vietnam 450
GB - Regno Unito 380
BD - Bangladesh 374
FR - Francia 336
DE - Germania 251
IN - India 155
NL - Olanda 154
CA - Canada 120
AR - Argentina 99
ID - Indonesia 82
AU - Australia 74
EE - Estonia 74
MX - Messico 67
CZ - Repubblica Ceca 54
ZA - Sudafrica 49
FI - Finlandia 48
EC - Ecuador 47
TR - Turchia 46
RU - Federazione Russa 40
JP - Giappone 37
UA - Ucraina 36
CO - Colombia 30
ES - Italia 28
IQ - Iraq 28
PH - Filippine 28
PK - Pakistan 25
CL - Cile 24
PL - Polonia 24
IR - Iran 21
MY - Malesia 21
SA - Arabia Saudita 21
MA - Marocco 20
PY - Paraguay 19
BE - Belgio 15
MD - Moldavia 15
TN - Tunisia 15
SE - Svezia 14
VE - Venezuela 13
AT - Austria 12
LT - Lituania 12
RO - Romania 12
JM - Giamaica 11
PE - Perù 10
AE - Emirati Arabi Uniti 9
AL - Albania 9
BO - Bolivia 9
CH - Svizzera 9
GR - Grecia 9
TH - Thailandia 9
UZ - Uzbekistan 9
DZ - Algeria 8
JO - Giordania 8
DO - Repubblica Dominicana 7
EG - Egitto 7
IL - Israele 6
KE - Kenya 6
NP - Nepal 6
UY - Uruguay 6
GE - Georgia 5
HN - Honduras 5
HU - Ungheria 5
NO - Norvegia 5
PT - Portogallo 5
TW - Taiwan 5
CR - Costa Rica 4
GT - Guatemala 4
IE - Irlanda 4
KZ - Kazakistan 4
MK - Macedonia 4
NI - Nicaragua 4
XK - ???statistics.table.value.countryCode.XK??? 4
AM - Armenia 3
AO - Angola 3
AZ - Azerbaigian 3
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
BY - Bielorussia 3
ET - Etiopia 3
GA - Gabon 3
KW - Kuwait 3
LK - Sri Lanka 3
OM - Oman 3
SV - El Salvador 3
BH - Bahrain 2
CG - Congo 2
CM - Camerun 2
CY - Cipro 2
DK - Danimarca 2
KG - Kirghizistan 2
KR - Corea 2
LB - Libano 2
LU - Lussemburgo 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
Totale 23.280
Salva come PNG Salva come JPEG
Città #
San Jose 1.801
Ashburn 1.460
Singapore 1.250
Hong Kong 1.072
Rome 844
Hefei 615
Dallas 415
Boardman 370
Beijing 333
Lauterbourg 281
London 276
Shanghai 208
Ho Chi Minh City 150
Council Bluffs 120
Amsterdam 109
Hanoi 108
Santa Clara 102
Los Angeles 93
New York 88
Munich 75
Milan 69
Tallinn 69
São Paulo 59
San Francisco 47
Mexico City 44
Washington 44
Frankfurt am Main 41
Seattle 41
Brno 39
Pune 33
Buffalo 30
Tokyo 30
Helsinki 29
Montreal 29
Toronto 29
Rio de Janeiro 27
Chicago 26
Las Vegas 26
West Jordan 26
Brooklyn 24
Chennai 23
Melbourne 23
Orem 23
Perth 22
Warsaw 19
Johannesburg 18
Turku 18
Bologna 17
Jinan 17
Naples 17
Qingdao 17
Turin 17
Atlanta 16
Boston 16
Santiago 16
Da Nang 15
Guayaquil 15
Manchester 15
Nuremberg 15
Quito 15
Brasília 14
Jakarta 14
Porto Alegre 14
Xi'an 14
Bari 13
Haiphong 13
Hangzhou 13
Reggio Emilia 13
Salvador 13
Shenzhen 13
Thái Bình 13
Sydney 12
Belo Horizonte 11
Bengaluru 11
Biên Hòa 11
Dhaka 11
Hanover 11
Palermo 11
Philadelphia 11
Bắc Ninh 10
Delhi 10
Hải Dương 10
Olomouc 10
Oxford 10
Stockholm 10
Zhengzhou 10
Buenos Aires 9
Campinas 9
Can Tho 9
Changsha 9
Denver 9
Florence 9
Kuala Lumpur 9
Paris 9
Staten Island 9
Ankara 8
Asunción 8
Baghdad 8
Bogotá 8
Canberra 8
Totale 11.313
Salva come PNG Salva come JPEG
Nome #
Circadian variations of platelet reactivity on clopidogrel in patients treated with elective percutaneous coronary intervention 444
Leptin as predictor of cardiovascular events and high platelet reactivity in patients undergoing percutaneous coronary intervention 271
Characterization of inflammatory profile by breath analysis in chronic coronary syndromes 244
Current management and prognosis of patients with recurrent myocardial infarction 243
Takotsubo Syndrome and Coronary Artery Disease: Which Came First-The Chicken or the Egg? 240
3D transesophageal echocardiographic assessment of acute reverse remodeling of the tricuspid annulus after transcatheter edge-to-edge repair 238
Contrast-induced Acute Kidney Injury in Diabetic Patients and SGLT-2 Inhibitors: A Preventive Opportunity or Promoting Element? 238
Antithrombotic treatment in patients with atrial fibrillation undergoing coronary angioplasty: rational convincement and supporting evidence 236
Designing the Optimal Procedure: Role of CT Scan in the Planning of Transcatheter Structural Heart Interventions 234
Coronary Chronic Total Occlusion Revascularization: When, Who and How? 230
Assessment of cardiopulmonary capacity in deconditioned athletes because of knee injury 230
An open international registry to evaluate medical and surgical outcomes of aortic valve insufficiency and ascending aorta aneurysm. 226
Current diagnostic ECG criteria for left ventricular hypertrophy: is it time to change paradigm in the analysis of data? 226
Prediction of type 4a myocardial infarction with the angiography-derived hemodynamic (ADDED) index 225
Simultaneous presence of Brugada and overgrowth syndromes 223
Emerging from the Darkness. Sudden Cardiac Death in Cardiac Amyloidosis 223
Current Applications and New Perspectives in Optical Coherence Tomography (OCT) Coronary Atherosclerotic Plaque Assessment: From PCI Optimization to Pharmacological Treatment Guidance 223
Antithrombotic Strategies in Patients with Atrial Fibrillation and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention 222
A sudden right-to-left shunt: the importance of evaluating patent foramen ovale during exercise 221
Carcinoid Pulmonary Valve Stenosis: Multimodality Imaging and Transcatheter Valve Implant With Prestenting Technique 219
Platelet reactivity and clinical outcomes following percutaneous coronary intervention in complex higher-risk patients 218
Association of bone biomarkers with advanced atherosclerotic disease in people with overweight/obesity 214
Association Between Platelet Reactivity and Long-Term Bleeding Complications After Percutaneous Coronary Intervention According to Diabetes Status 213
Antithrombotic treatment for valve prostheses: Which drug, which dose, and when? 213
Acute pharmacological tests in patients with primary and precapillary secondary pulmonary hypertension 210
Additional value of T1 and T2 mapping techniques for early detection of myocardial involvement in scleroderma 208
Accelerated QRS widening as an independent predictor of cardiac death or of the need for heart transplantation in patients with congestive heart failure. 207
Age and heart transplantation: results from a heart failure management unit. 207
Glycaemic Control in Patients Undergoing Percutaneous Coronary Intervention: What Is the Role for the Novel Antidiabetic Agents? A Comprehensive Review of Basic Science and Clinical Data 203
Cardiovascular and metabolic effects of hyperbilirubinemia in a cohort of Italian Olympic athletes 202
Andamento dei livelli plasmatici dei neurormoni dopo il trapianto cardiaco 200
Relationship Between the Completeness of Revascularization and Myocardial Injury in Patients Treated With Percutaneous Coronary Intervention 192
Incretins-Based Therapies and Their Cardiovascular Effects: New Game-Changers for the Management of Patients with Diabetes and Cardiovascular Disease 173
Acute and chronic haemodynamic effects of biventricular pacing and of switching to different pacing modalities in heart failure patients 157
A State-of-the-Art Review on Sleep Apnea Syndrome and Heart Failure 149
A novel tricuspid flow optimiser for severe tricuspid regurgitation (TRiFlO) 149
Integrating platelet reactivity in the age, creatinine and ejection fraction score to predict clinical outcomes following percutaneous coronary intervention in patients with chronic coronary syndrome: the PR-ACEF score 145
Impact of burden and distribution of aortic valve calcification on the hemodynamic performance and procedural outcomes of a self-expanding, intra-annular transcatheter aortic valve system 144
Beyond the Calcium Score: What Additional Information from a CT Scan Can Assist in Cardiovascular Risk Assessment? 144
Long Stent Implantation on the Left Anterior Descending Coronary Artery at a Follow-Up of More Than Five Years 140
Arrhythmias after COVID-19 Vaccination: Have We Left All Stones Unturned? 134
Early GLS changes detection after chemoradiation in locally advanced non-small cell lung cancer (NSCLC) 131
Impact of endothelial dysfunction on long-term clinical outcomes in patients with chronic coronary syndromes treated with second generation drug-eluting stent implantation 130
Non-INvasive Functional and Anatomic vascular evaluation for the prediction of coronary artery disease: The NINFA study 129
The MIDA-Q Mortality Risk Score: A Quantitative Prognostic Tool for the Mitral Valve Prolapse Spectrum 129
A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensus 127
Combined procedure of transcatheter aortic valve replacement and coronary intravascular lithotripsy 124
Breath Analysis via Gas Chromatography-Mass Spectrometry (GC-MS) in Chronic Coronary Syndrome (CCS): A Proof-of-Concept Study 124
Impact of oral anticoagulant regimens on occurrence of contrast-induced nephropathy in patients undergoing coronary angioplasty 120
Correction to: The Role of Angiogenesis and Arteriogenesis in Myocardial Infarction and Coronary Revascularization 119
Cardiotoxicity of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy: Pathophysiology, Clinical Implications, and Echocardiographic Assessment 119
Acute heart failure in patients with acute aortic syndrome: Pathophysiology and clinical-prognostic implications 117
Aortic Valve Surgery in Nonelderly Patients: Insights Gained From AVIATOR 115
Fractional Flow Reserve-Guided Coronary Revascularization: Evidence from Randomized and Non-Randomized Studies 113
Incremental role of glycaemic variability over HbA1c in identifying type 2 diabetic patients with high platelet reactivity undergoing percutaneous coronary intervention 113
Prediction of 5-Year Mortality in Patients with Chronic Coronary Syndrome Treated with Elective Percutaneous Coronary Intervention: Role of the ACEF Score 113
DOACs vs Vitamin K Antagonists During Cardiac Rhythm Device Surgery: A Multicenter Propensity-Matched Study 112
Invasive Assessment of Coronary Microvascular Function 107
The Spectrum of Coronary Artery Disease in Elite Endurance Athletes-A Long-Standing Debate: State-of-the-Art Review 105
Assessment of mitral regurgitation through Doppler echocardiography: Feasibility, pitfalls and diagnostic advantages 105
Impact of Mediterranean diet on metabolic and inflammatory status of patients with polyvascular atherosclerotic disease 101
Tricuspid regurgitation: what is the real clinical impact and how often should it be treated? 99
Systematic review and meta-analysis of randomized and nonrandomized studies on fractional flow reserve-guided revascularization 98
Athlete's ECG Made Easy: A Practical Guide to Surviving Everyday Clinical Practice 97
Effects of Finerenone on Cardiovascular and Chronic Kidney Diseases: A New Weapon against Cardiorenal Morbidity and Mortality-A Comprehensive Review 97
Chemoreceptor hyperactivity in heart failure: Is lactate the culprit? 96
Disproportionate Left Ventricular Enlargement in Mitral Valve Prolapse: Prevalence, Predictors, and Association With Outcomes 93
Length and Type of Antibiotic Prophylaxis for Infection Prevention in Adults Patient in the Cardiac Surgery Intensive Care Unit: A Narrative Review 87
Relation of endothelin-1 to survival in patients with primary pulmonary hypertension 87
Practical Guidance for the Use of SGLT2 Inhibitors in Heart Failure 85
The current paradigm of cardiac troponin increase among athletes 85
Edge-to-edge repair for tricuspid regurgitation: 1-year follow-up and clinical implications from the TR-Interventional Study 82
Severe heart failure and intracardiac thrombosis: going beyond the appearance for diagnosis and treatments 81
Relazione comparativa tra capacità funzionale e profilo emodinamico in pazienti con scompenso cardiaco cronico biventricolare o scompenso cardiaco destro puro 80
In Stent Neo-Atherosclerosis: Pathophysiology, Clinical Implications, Prevention, and Therapeutic Approaches 77
Impact of cardiovascular disease on clinical outcomes in hospitalized patients with Covid-19: a systematic review and meta-analysis 76
Valutazione italiana del "Minnesota Living with Heart Failure Questionnaire" 75
Extracorporeal Membrane Oxygenation Support in Refractory Cardiogenic Shock: Treatment Strategies and Analysis of Risk Factors 74
Indexing left ventricular end-systolic dimension to body size: Association with mortality in patients with degenerative mitral regurgitation 73
Cardiac involvement of Gorlin-Goltz syndrome: new light among the shadows of an old congenital disorder 73
Cyclosporine lowering with everolimus versus mycophenolate mofetil in heart transplant recipients: long-term follow-up of the SHIRAKISS randomized, prospective study 70
Traditional and Advanced Echocardiographic Evaluation in Chronic Obstructive Pulmonary Disease: The Forgotten Relation 69
Eosinophilic Myocarditis: From Bench to Bedside 69
The safety of transesophageal echocardiography to guide transcatheter tricuspid valve edge-to-edge repair 68
Platelet function and markers of atherothrombotic risk in individuals with parathyroid disorders 68
Twenty-Year Outcome after Mitral Repair Versus Replacement for Severe Degenerative Mitral Regurgitation: Analysis of a Large, Prospective, Multicenter, International Registry 67
Prognostic stratification of women with chronic heart failure referred for heart transplantation: relevance of gender as compared with gender-related characteristics. 67
Evaluation of postural disorders in patients pre and post heart transplant. 66
The butterfly effect: Restoring the tricuspid coaptation after clipping the antero-septal commissure 65
Evaluation of Cardiac Autonomic Function in Patients Undergoing Thoracoscopic Sympathetic Chain Clamping for Primary Focal Hyperhidrosis 64
The Central Role of Left Atrium in Heart Failure 63
Histological and histometric characterization of myocardial fibrosis in end-stage hypertrophic cardiomyopathy. A Clinical-Pathological Study of 30 Explanted Hearts 63
Impact of Chronic Kidney Disease and Platelet Reactivity on Clinical Outcomes Following Percutaneous Coronary Intervention 62
Usefulness of Adding Pre-procedural Glycemia to the Mehran Score to Enhance Its Ability to Predict Contrast-induced Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention Development and Validation of a Predictive Model 62
Optimizing Management of Stable Angina: A Patient-Centered Approach Integrating Revascularization, Medical Therapy, and Lifestyle Interventions 60
Prognostic implications of functional tricuspid regurgitation in asymptomatic degenerative mitral regurgitation 60
The Pivotal Role of Invasive Functional Assessment in Patients With Myocardial Infarction With Non-Obstructive Coronary Arteries (MINOCA) 59
Role of polypill in cardiovascular prevention and treatment 59
Management of asymptomatic mitral regurgitation. 58
Impact of Pre-Transplant Pulmonary Hypertension Grading on Early- to Long-Term Hemodynamics, Right Venticular Graft Function and Survival After Heart Transplantation 57
Totale 13.922
Salva come PNG Salva come JPEG
Categoria #
all - tutte 143.180
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 143.180
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022331 0 2 7 11 6 9 6 3 15 16 13 243
2022/2023283 10 9 22 18 29 4 10 11 6 7 153 4
2023/20241.461 24 115 82 90 109 459 58 304 64 72 24 60
2024/202510.194 211 100 368 177 83 286 192 61 760 713 3.500 3.743
2025/202610.963 822 376 849 1.295 435 674 2.595 931 901 963 654 468
2026/2027276 276 0 0 0 0 0 0 0 0 0 0 0
Totale 23.508